Biomolecules (Jun 2015)

Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications

  • Matthew R. Pratt,
  • Tharindumala Abeywardana,
  • Nicholas P. Marotta

DOI
https://doi.org/10.3390/biom5031210
Journal volume & issue
Vol. 5, no. 3
pp. 1210 – 1227

Abstract

Read online

α-Synuclein is the aggregation-prone protein associated with Parkinson’s disease (PD) and related neurodegenerative diseases. Complicating both its biological functions and toxic aggregation are a variety of posttranslational modifications. These modifications have the potential to either positively or negatively affect α-synuclein aggregation, raising the possibility that the enzymes that add or remove these modifications could be therapeutic targets in PD. Synthetic protein chemistry is uniquely positioned to generate site-specifically and homogeneously modified proteins for biochemical study. Here, we review the application of synthetic peptides and proteins towards understanding the effects of α-synuclein posttranslational modifications.

Keywords